Understanding how HIV interacts with a new animal model

Characterizing Host-Virus Interactions in a New HIV Model Organism

NIH-funded research University of Colorado · NIH-10895992

This study is looking at how HIV works and hides from the immune system using a new animal model, which could help scientists create better treatments and vaccines for people living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado NIH-funded
Lab location1 site (Boulder, UNITED STATES)
Project IDNIH-10895992 on NIH RePORTER

What this research studies

This research investigates the interactions between HIV and a newly developed animal model to better understand the virus's behavior and its ability to evade the immune system. By designing and testing specific strains of HIV-1, the researchers aim to optimize how these viruses bind to host factors in the new model. The study will also assess how effectively these viruses can be neutralized by antibodies, providing insights into potential vaccine development. This work is crucial for advancing our understanding of HIV and developing effective treatments or vaccines.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV or those at high risk of HIV infection who are interested in contributing to the advancement of HIV treatment and prevention.

Not a fit: Patients who are not living with HIV or at risk of HIV infection may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in HIV vaccine development and improved treatment strategies.

How similar studies have performed: While there have been successful studies using animal models for HIV research, this specific approach with a new model organism is relatively novel and untested.

Where this research is happening

Boulder, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.